BioNTech at ENA 2026

Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website

BioNTech brings 2 presentations to ENA 2026 in Barcelona. Its program spans antibody-drug conjugates and immunotherapy, including a lecture on immunotherapy innovations. It also presents preclinical results for BNT329, an antibody-drug conjugate targeting the sialyl Lewis A antigen CA19-9.

OrganizationENA 2026 Attendance
BioNTech
Mainz, Germany
biontech.com
Biotech
Immunotherapy company developing mRNA vaccines, cell therapies, bispecific antibodies and antibody-drug conjugates for cancer.
Poster
Wed Nov 18
12–1:30pm
3:50–4:15pm
5:45–7pm
Plenary
Fri Nov 20
11:15am–12pm

Explore the full ENA 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Barcelona. Leave your work email and we’ll be in touch.

Privacy

Download the full ENA 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from BioNTech

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction